Poly(lactide)–vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel
Authors:
- Si-Shen FengSFSi-Shen Feng
- Lin MeiLMLin Mei
- Panneerselvan AnithaPAPanneerselvan Anitha
- Chee Wee GanCGChee Wee Gan
- Wenyou ZhouWZWenyou Zhou
- 1 July 2009
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 30 (19) , 3297-3306
Abstract
No abstract availableKeywords
Funding Information
- National University of Singapore (R-279-000-226-112)
This publication has 38 references indexed in Scilit:
- Nanoparticles of Biodegradable Polymers for Cancer TreatmentBiomaterials, 2008
- Overview of the changing paradigm in cancer treatment: Oral chemotherapyAmerican Journal of Health-System Pharmacy, 2007
- Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: Synthesis, formulation, characterization and in vitro drug releaseBiomaterials, 2006
- Oral delivery of spray dried PLGA/amifostine nanoparticlesJournal of Pharmacy and Pharmacology, 2004
- Pharmacological Effects of Formulation VehiclesClinical Pharmacokinetics, 2003
- Enhanced intestinal absorption of vancomycin with Labrasol and d-α-tocopheryl PEG 1000 succinate in ratsInternational Journal of Pharmaceutics, 2003
- A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrierBiomaterials, 2002
- Cremophor ELEuropean Journal of Cancer, 2001
- Chemotherapy of breast cancer: are the taxanes going to change the natural history of breast cancer?Expert Opinion on Pharmacotherapy, 2000
- Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cellsBiochemical and Biophysical Research Communications, 1991